Herbal formula

Bronchicum (Thyme and Primula)

Also known as Bronchicum Elixir, Bronchicum Tropfen, Bronchipret TP, Bronchipret TP FCT, thyme–primula, thyme and primrose root, Thymi herba and Primulae radix

German thyme–primula cough medicines with adult placebo trials and an EMA well-established-use monograph for certain fixed preparations.

Main use: Acute bronchitis with productive (chesty) cough

Good clinical evidence

2 ingredients

Updated November 16, 2026

Key points

  1. 01

    Two placebo trials in adults

    Bronchicum Tropfen beat placebo in 150 adults (Gruenwald 2005). Bronchipret TP tablets cut daytime coughing fits 67.1% versus 51.3% in 361 adults (Kemmerich 2007).

  2. 02

    EMA rates certain pairs well-established

    The 2016 EU monograph accepts three fixed thyme–primula preparations as well-established expectorants for productive cough in adults; other versions are traditional only.

  3. 03

    Root, not flower

    These products use cowslip or oxlip root. Sinupret uses primula flower in a five-herb sinus formula; that is a different drug and a different indication.

  4. 04

    Alcohol and age differ by product

    Bronchicum Elixir is about 4.9% alcohol by volume and labeled from 6 months in Germany; the drops are about 28% alcohol from age 6; Bronchipret TP tablets start at 12.

  5. 05

    Stomach, allergy, and red flags

    Expect occasional stomach upset. Avoid with mint-family allergy; take care with gastritis or ulcers; see a doctor for breathlessness, fever, or bloody phlegm.

Thyme and primula is a fixed combination of extracts from thyme herb (Thymus vulgaris or Thymus zygis) and primula root, the underground parts of cowslip (Primula veris) or oxlip (Primula elatior), sold as medicines for chesty coughs with thick mucus. In Germany the best-known liquids are Bronchicum Elixir and Bronchicum Tropfen, made by Cassella-med (Klosterfrau group). Their current labels still name thyme herb fluid extract plus primula root fluid extract (elixir) or primula root tincture (drops). A sister dry-extract tablet, Bronchipret TP from Bionorica, pairs 160 mg thyme dry extract with 60 mg primula root dry extract; that tablet is the product tested in the largest placebo-controlled trial. Other Bronchicum line extensions contain thyme alone, and Bronchipret’s syrup and drops pair thyme with ivy leaf instead of primula, so the front of the box is not enough: check that both thyme and primula root are listed.

Both plants have long European cough histories, though the root’s modern career as a pharmacy expectorant is newer than the flower’s folklore. According to the European Medicines Agency (EMA), fixed thyme–primula combinations have been in medicinal use in the EU since at least 1976. EMA’s Committee on Herbal Medicinal Products published a combination monograph in 2016 that grants well-established use, its stronger category, to three specific adult preparations as expectorants for productive cough, and traditional use to several others for cough associated with a cold. That is a sharper regulatory footing than thyme with ivy, which has national licenses and trials but no EU combination monograph. EMA’s assessors read “acute bronchitis” in the German trials as a common cold with productive cough, and they restricted the well-established forms to adults because children were not in the controlled efficacy trials.

How the combination works is not settled. Product information for Bronchicum and Bronchipret TP describes weak expectorant and antispasmodic effects for thyme and a reflex increase in watery airway secretion from poorly absorbed primula saponins that irritate the stomach lining. EMA’s public summary says laboratory work suggests thyme may act against microbes and relax muscle while primula root may dilute phlegm, and its monograph states that the mechanism of action is not known. This page covers the ingredients and amounts, the trials of the combination itself, how the main German products are labeled to be taken, and who should avoid them. Results belong to the tested products and extract pairs, not to thyme or cowslip on their own, and not to teas or homemade syrups. Nothing here is medical advice.

02 The blend

What’s in it

Ingredients in label order. Results from trials of this formula belong to the combination, not to any single herb in it.

  1. Thyme · Herb (leaf and flower), fluid or dry extract

    Bronchicum Elixir: 6.635 g fluid extract (1:2–2.5) per 100 ml; Bronchicum Tropfen: 43.4 g per 100 ml; Bronchipret TP: 160 mg dry extract (6–10:1) per tablet

    Thymus vulgaris

    Thymus vulgaris or Thymus zygis herb, the same plant part EMA covers as a traditional single-herb expectorant. The ammonia–glycerol–ethanol fluid extract matches the German Pharmacopoeia type used in Bronchicum liquids; the tablet uses a 70% ethanol dry extract. Trial results belong to the fixed combinations, not to thyme alone.

    Read the thyme monograph →

  2. Cowslip (primula) · Root (rhizome and roots), fluid extract, tincture, or dry extract

    Bronchicum Elixir: 3.318 g fluid extract (1:2–2.5) per 100 ml; Bronchicum Tropfen: 21.7 g root tincture (1:5) per 100 ml; Bronchipret TP: 60 mg dry extract (6–7:1) per tablet

    Primula veris

    Primula veris or Primula elatior root, not the flower used in Sinupret. EMA accepts primula root alone as a traditional expectorant for cough with a cold; no published trial has tested the root on its own. The saponin-rich root is the partner in every thyme–primula product on this page.

    Read the cowslip monograph →

03 Evidence

What the research shows

Good clinical evidence

Our rating for acute bronchitis with productive (chesty) cough, based on trials of this combination.

The first placebo-controlled trial of a marketed liquid is Gruenwald, Graubaum, and Busch (Arzneimittel-Forschung 2005), summarized in detail in EMA’s 2016 assessment report. One hundred and fifty adults with untreated acute bronchitis lasting under 48 hours took Bronchicum Tropfen, 30 drops (1 ml) five times daily, or placebo for 7–9 days. The Bronchitis Severity Score (BSS), which rates cough, sputum, rales, chest pain on coughing, and breathlessness from 0 to 4 each, fell from 12.0 to 1.0 points with the drops and from 11.7 to 6.5 with placebo, a highly significant 5.8-point gap. At the end, 58.7% of people on the drops were symptom-free against 5.3% on placebo. Two adverse events occurred with the drops (stomach ache and nausea judged related) versus five with placebo; none was serious. The trial dose matches EMA’s well-established liquid-plus-tincture preparation (about 0.43 g thyme fluid extract and 0.21 g primula root tincture per dose). Current German adult labeling for Bronchicum Tropfen is 35 drops five times daily, a little higher per drop count than the trial’s 30 drops.

A year later, Gruenwald and colleagues (Arzneimittel-Forschung 2006) compared Bronchicum Elixir S, 5 ml six times daily, with Bronchicum Tropfen, 1 ml five times daily, in 189 adults for 7–9 days, without a placebo arm. The BSS fell from 11.0 to 2.6 points with the elixir and from 11.0 to 2.5 with the drops; about half of each group was symptom-free at the end. The study supports similar short-term symptom change between those two liquids, not superiority over doing nothing. Today’s Bronchicum Elixir Fachinformation (January 2024) still cites both Bronchicum trials and lists adult dosing as 7.5 ml four times daily; each 7.5 ml supplies about 0.5 g thyme fluid extract and 0.25 g primula root fluid extract, the single dose EMA lists for its second well-established liquid, though the labeled daily schedule is four doses rather than the six used in the 2006 trial.

The largest placebo trial is Kemmerich (Arzneimittelforschung 2007). In a double-blind, multicenter phase IV study, 361 adults with acute bronchitis, at least 10 daytime coughing fits, recent sticky mucus, and a BSS of at least 5 took Bronchipret TP film-coated tablets (n=183) or placebo (n=178), one tablet three times daily for 11 days. By days 7 to 9, daytime coughing fits had fallen 67.1% from baseline with the tablets and 51.3% with placebo; a 50% reduction came about two days sooner. Investigator-rated responder rates were 77.5% versus 60.1% on day 4 and 92.9% versus 75.8% at the end. Adverse events did not differ between groups, and none was serious. Each tablet holds 160 mg thyme dry extract (6–10:1, 70% ethanol) and 60 mg primula root dry extract (6–7:1, 47.4% ethanol), EMA’s third well-established preparation and about 1.17 g of primula root a day by the agency’s calculation. The abstract does not name a funder; Bionorica makes the product.

Head-to-head and pooled evidence put these results in context. Kardos and colleagues (Pharmaceuticals 2025), funded by Engelhard, which makes an ivy-only product, randomized 328 adults to ivy drops (Prospan), thyme–ivy drops (Bronchipret), or thyme–primrose drops (Bronchicum) for a week and analyzed 325. The BSS fell by 9.11 points with ivy alone, 7.64 with thyme–ivy, and 8.59 with thyme–primrose; ivy was non-inferior to both and statistically superior to thyme–ivy, but its edge over thyme–primrose missed significance (p=0.0607). Patients and doctors knew which product was used. Wagner, Cramer, and colleagues (Forschende Komplementärmedizin 2015) pooled four randomized trials of ivy-, primrose-, and thyme-based preparations and found a cough response about 40% more likely than with placebo (risk ratio 1.40, 95% confidence interval 1.23–1.60); that figure spans several products. A large observational comparison by Ernst and colleagues (1997), which EMA used mainly for safety, followed thousands of adults and children on the dry-extract tablet versus ambroxol or acetylcysteine without randomization or placebo.

Regulators treat the combination as a product class with tightly specified extracts. EMA’s 2016 monograph grants well-established use only to the three adult preparations that match the Gruenwald liquids and the Kemmerich tablet, as expectorants for productive cough; other extract pairs remain traditional medicines for cough with a cold, some from age 4. Well-established forms are not recommended under 18 for lack of controlled efficacy data in that age group. EMA’s public page notes a 2024 call for data for the monograph’s periodic review. In Germany, Bronchicum Elixir, Bronchicum Tropfen, and Bronchipret TP hold national pharmacy-only authorizations. In the United States these products are not approved cough drugs, and the over-the-counter expectorant monograph names guaifenesin alone. Open questions remain: independent replication of the placebo trials is limited, the contribution of each herb cannot be separated, young-child efficacy rests on uncontrolled studies, and an open-label competitor trial did not show thyme–primula beating ivy alone.

04 In practice

How it is taken

Three German pharmacy medicines cover the trial evidence. Bronchicum Elixir (Fachinformation, January 2024) contains 6.635 g thyme herb fluid extract (1:2–2.5, ammonia–glycerol–ethanol–water) and 3.318 g primula root fluid extract (1:2–2.5, 70% ethanol) per 100 ml, with 39 mg alcohol per ml (about 4.9% by volume), invert sugar, and sodium benzoate. Labeled doses are 1 ml six times daily from 6 to under 12 months, 2.5 ml six times daily from ages 1 to 4, and 7.5 ml four times daily from age 5 for older children, adolescents, and adults, taken with the supplied measuring aid. Bronchicum Tropfen (September 2023) contain 43.4 g of the same type of thyme fluid extract and 21.7 g primula root tincture (1:5, 50% ethanol) per 100 ml, plus sucrose, eucalyptus oil, and levomenthol; alcohol is 190 mg per 30 drops and 222 mg per 35 drops (27.7% by volume). From ages 6 to 12 the label gives 30 drops three to five times daily; from 12 and in adults, 35 drops five times daily, on sugar or in hot tea. Bronchipret TP tablets hold 160 mg thyme and 60 mg primula root dry extracts; adolescents from 12 and adults take one tablet three times daily, swallowed whole before meals with water. The tablets contain lactose and glucose syrup and no alcohol.

Match the product to the evidence you care about. The Gruenwald 2005 placebo result applies to the drops at about 1 ml five times daily; the Kemmerich 2007 result applies to Bronchipret TP at one tablet three times daily for about 11 days; the elixir’s placebo support is indirect, through the non-inferiority comparison with the drops. EMA’s well-established adult posologies are 0.43 g thyme fluid extract with 0.21 g primula root tincture five times daily, 0.5 g thyme fluid extract with 0.25 g primula root fluid extract six times daily, and 160 mg/60 mg dry extracts three times daily. Labels tell users to see a doctor if symptoms last more than a week (Bronchicum) or more than two weeks (Bronchipret TP), or sooner if they worsen. Do not stack a thyme–primula product with another thyme, primula, thyme–ivy, or ivy cough medicine.

When comparing brands elsewhere, read the leaflet for Thymus vulgaris or Thymus zygis herb and Primula veris or Primula elatior root, the extract type and ratio, the age band, and the alcohol content. Primula flower, evening primrose oil, and thyme-only Bronchicum line extensions are different products. Acute bronchitis often settles in around three weeks with rest and fluids, so a herbal expectorant is optional, and this page does not recommend any brand. Stop if allergy signs appear, and keep alcoholic drops out of young children’s reach.

05 Caution

Before you use Bronchicum (Thyme and Primula)

Stomach upset is the main expected effect. EMA’s combination monograph lists gastric disorders and nausea at unknown frequency. Bronchicum Elixir lists hypersensitivity reactions (rash, hives, angioedema with breathlessness) and stomach and bowel complaints (cramps, nausea, vomiting, diarrhea) without a stated frequency, and notes that vomiting can be common in infants under 12 months. Bronchicum Tropfen lists very rare hypersensitivity reactions and stomach complaints, and warns that levomenthol and eucalyptus oil can trigger reactions, including breathlessness, in sensitized people. Bronchipret TP lists uncommon stomach and bowel complaints (up to 1 in 100) and very rare hypersensitivity with breathlessness, rash, hives, or swelling of the face, mouth, or throat; at the first sign of allergy the tablet must not be taken again. In the Gruenwald and Kemmerich placebo trials, related adverse events were few and matched or undercut placebo, with no serious events. Overdose may intensify stomach upset, vomiting, or diarrhea.

Do not use these products with allergy to thyme or other mint-family plants (Lamiaceae). Bronchipret TP also contraindicates allergy to birch, mugwort, or celery, and Bronchicum Tropfen contraindicates allergy to levomenthol or eucalyptus oil. EMA advises caution in gastritis or stomach ulcer because saponins irritate the stomach lining. Age limits differ: German Bronchicum Elixir is labeled from 6 months, the drops from 6 years, and Bronchipret TP from 12 years, while EMA does not recommend its well-established thyme–primula preparations under 18. Pregnancy and breastfeeding are not recommended on the German labels or by EMA, because safety has not been established. People with hereditary fructose intolerance should avoid the sugar-containing liquids; people who cannot digest lactose or galactose should avoid Bronchipret TP. Diabetics should count the carbohydrate in the elixir and drops.

No drug interactions are reported for the combination, and none have been formally studied. The alcohol in the liquids, especially the drops at roughly 28% by volume, can add to other medicines containing ethanol or propylene glycol and matters in alcohol dependence. Taking an expectorant together with a cough suppressant such as codeine or dextromethorphan works at cross purposes; ask a pharmacist before combining cough products. Thyme–ivy syrups, single-herb ivy, and multi-herb cough mixtures overlap with this combination, so do not double up.

These products are for an ordinary chesty cough with a cold, not for breathing trouble or a cough that will not go away. Bronchicum labels say to see a doctor promptly if symptoms last more than a week or if breathlessness, fever over 39 °C, or pus-like or bloody phlegm appears; Bronchipret TP uses a two-week symptom window and the same red flags. The UK National Health Service (NHS) advises an urgent appointment for a cough lasting more than three weeks that is not getting better, coughing up blood, chest pain on breathing or coughing, shortness of breath, or feeling too unwell for usual activities, and the same advice for people over 65, pregnant people, those with a long-term condition such as diabetes or a heart, lung, or kidney condition, and anyone with a weakened immune system. Call emergency services for struggling to breathe, lips or skin turning pale, blue, or gray, sudden confusion, or a baby who is floppy or cannot be woken. The products are not treatments for asthma, chronic obstructive pulmonary disease (COPD), pneumonia, or whooping cough.

06 Questions

Frequently Asked Questions

In adults, specific products probably help a little more than placebo. Thyme with primula root drops (Bronchicum Tropfen) cleared symptoms in 58.7% of 150 adults versus 5.3% on placebo after about a week, and Bronchipret TP tablets cut daytime coughing fits by 67.1% versus 51.3% in 361 adults. EMA rates those extract pairs as well-established expectorants for productive cough in adults. Bronchitis often settles in around three weeks either way. See our herbs for cough guide for other options.

No. Bronchicum Elixir and Tropfen are Cassella-med liquids of thyme herb with primula root. Bronchipret TP is a Bionorica tablet of dry thyme and primula root extracts, the product in the 361-adult placebo trial. Bronchipret Saft and Tropfen are different again: they pair thyme with ivy leaf, covered on our thyme and ivy page. Always read which second herb is on the label.

Same genus, different plant part and product. Cough combinations use cowslip or oxlip root. Sinupret uses primula flower among five herbs for sinusitis. EMA’s thyme–primula monograph covers the root only. Flower and root are separate herbal drugs with separate age limits and evidence.

The elixir contains 39 mg alcohol per ml (about 4.9% by volume). The drops are much stronger: 222 mg per adult 35-drop dose, or 27.7% by volume. Bronchipret TP tablets contain no alcohol. Alcohol content matters in pregnancy, breastfeeding, alcohol dependence, and young children, and when other ethanol-containing medicines are used.

It depends on the product. In Germany Bronchicum Elixir is labeled from 6 months, Bronchicum Tropfen from 6 years, and Bronchipret TP from 12 years. EMA does not recommend its well-established thyme–primula preparations under 18, because controlled efficacy trials enrolled adults only; some traditional combinations may be used from age 4. Ask a doctor before giving any cough medicine to a young child. Our ivy leaf for cough review covers another common pediatric option.

It is not recommended. German Bronchicum and Bronchipret TP labels advise against use in pregnancy and breastfeeding because studies are lacking, and EMA says the same for the combination. The liquids also contain alcohol. The NHS lists pregnancy among reasons to get a cough checked promptly, and favors rest, fluids, and honey in a warm drink for ordinary bronchitis self-care.

Both beat placebo in separate 361-adult bronchitis trials, and both are used for chesty cough. Thyme–primula has an EU well-established-use monograph for certain adult preparations; thyme–ivy does not. In a 2025 open-label trial, ivy alone looked at least as good as either combination. Results for one product do not transfer to the other; see thyme and ivy (Bronchipret).

Product labels say to see a doctor if the cough lasts more than a week or two, or if you become breathless, develop a high fever, or cough up pus-like or bloody phlegm. The NHS adds a cough lasting more than three weeks, chest pain, and being over 65, pregnant, or living with a long-term condition or a weakened immune system. Struggling to breathe, blue or gray lips, or sudden confusion needs emergency care.

07 References

Sources

These references support the claims on this page. They are not an endorsement of any product. Each ingredient’s monograph carries its own full source list.

  1. Efficacy and Tolerability of a Fixed Combination of Thyme and Primrose Root in Patients with Acute Bronchitis

    Arzneimittel-Forschung (PubMed 16366041), 2005

    Gruenwald, Graubaum, Busch: double-blind trial, 150 adults, Bronchicum Tropfen 30 drops (1 ml) five times daily for 7–9 days; BSS 12.0 to 1.0 versus 11.7 to 6.5 with placebo; 58.7% versus 5.3% symptom-free.

  2. Evaluation of the non-inferiority of a fixed combination of thyme fluid- and primrose root extract in comparison to a fixed combination of thyme fluid extract and primrose root tincture in patients with acute bronchitis

    Arzneimittel-Forschung (PubMed 17009838), 2006

    Gruenwald et al.: 189 adults, Bronchicum Elixir S 5 ml six times daily versus Bronchicum Tropfen 1 ml five times daily for 7–9 days; BSS fell similarly (11.0 to 2.6 versus 2.5); no placebo arm.

  3. Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough

    Arzneimittelforschung (PubMed 17966760), 2007

    Kemmerich: double-blind phase IV trial, 361 adults, Bronchipret TP one tablet three times daily for 11 days; coughing fits down 67.1% versus 51.3% with placebo; responders 92.9% versus 75.8% at end.

  4. European Union herbal monograph on Thymus vulgaris L. or Thymus zygis L., herba and Primula veris L. or Primula elatior (L.) Hill, radix

    European Medicines Agency (EMA/HMPC/84990/2015), 2016

    Final monograph 5 April 2016: three well-established adult preparations for productive cough; traditional use for other combinations; gastritis caution; pregnancy not recommended; WEU not under 18.

  5. Assessment report on Thymus vulgaris L. or Thymus zygis L., herba and Primula veris L. or Primula elatior (L.) Hill, radix

    European Medicines Agency (EMA/HMPC/85124/2015), 2016

    Maps Gruenwald 2005/2006 and Kemmerich 2007 to WEU a/b/c; reads acute bronchitis as common cold with productive cough; child observational safety data; WEU restricted to adults.

  6. Combination: Thymi herba and Primulae radix — herbal medicinal product

    European Medicines Agency, Committee on Herbal Medicinal Products, 2016

    Public summary: certain combinations well-established for productive cough in adults; others traditional for cold-related cough; 2024 call for data for periodic review.

  7. Fachinformation: Bronchicum Elixir

    Cassella-med GmbH & Co. KG, via Fachinfo-Service, 2024

    January 2024: 6.635 g thyme and 3.318 g primula root fluid extract per 100 ml; 39 mg ethanol/ml; doses from 6 months; pregnancy not recommended; cites Tropfen placebo trial and elixir non-inferiority trial.

  8. Fachinformation: Bronchicum Tropfen

    Cassella-med GmbH & Co. KG, via Fachinfo-Service, 2023

    September 2023: 43.4 g thyme fluid extract and 21.7 g primula root tincture per 100 ml; 27.7% V/V alcohol; 35 drops five times daily from age 12; not under 6; eucalyptus oil and levomenthol.

  9. Fachinformation: Bronchipret TP

    Bionorica SE, via Fachinfo-Service, 2014

    September 2014: 160 mg thyme dry extract and 60 mg primula root dry extract per tablet; from age 12; gastritis caution; birch/mugwort/celery allergy; pregnancy not recommended; lactose.

  10. Gebrauchsinformation: Bronchipret TP Filmtabletten

    Bionorica SE, 2024

    Patient leaflet: see a doctor if symptoms last more than two weeks or if breathlessness, fever, or pus-like or bloody phlegm appears; dose one tablet three times daily from age 12.

  11. Efficacy and safety of a single ivy extract versus two herbal extract combinations in patients with acute bronchitis: a multi-center, randomized, open-label clinical trial

    Pharmaceuticals (PubMed 40430571), 2025

    Kardos et al.: 325 adults analyzed; BSS fell 9.11 with ivy, 7.64 with thyme–ivy, 8.59 with Bronchicum (thyme–primrose) drops; ivy non-inferior to both; Engelhard-funded.

  12. Herbal medicine for cough: a systematic review and meta-analysis

    Forschende Komplementärmedizin (PubMed 26840418), 2015

    Wagner, Cramer and colleagues: four RCTs of ivy, primrose, and thyme preparations; risk ratio 1.40 (95% CI 1.23–1.60) for cough response versus placebo.

  13. Bronchitis

    NHS (UK National Health Service), 2026

    Bronchitis often settles in around three weeks; urgent and emergency warning signs, including a cough over three weeks, coughing blood, chest pain, breathlessness, and higher-risk groups.

  14. Community herbal monograph on Thymus vulgaris L. and Thymus zygis L., herba

    European Medicines Agency (EMA/HMPC/342332/2013), 2013

    Thyme alone as traditional use for productive cough with a cold; Lamiaceae allergy contraindication; pregnancy not recommended.

  15. Community herbal monograph on Primula veris L. and/or Primula elatior (L.) Hill, radix

    European Medicines Agency (EMA/HMPC/104095/2012), 2012

    Primula root alone as traditional expectorant for cough with a cold; caution in gastritis or gastric ulcer; not recommended in pregnancy.

Related formulas

All formulas →